Direct-to-Patient Mobile Teledermoscopy: Prospective Observational Study.

JMIR Dermatol

Department of Dermatology, School of Medicine, University of California San Francisco, San Francisco, CA, United States.

Published: February 2024

Direct-to-patient mobile teledermoscopy is a feasible and useful adjunct to smartphone imaging for monitoring patient-identified lesions of concern, achieving comparable diagnostic and management accuracy as in-office dermatology.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10897786PMC
http://dx.doi.org/10.2196/52400DOI Listing

Publication Analysis

Top Keywords

direct-to-patient mobile
8
mobile teledermoscopy
8
teledermoscopy prospective
4
prospective observational
4
observational study
4
study direct-to-patient
4
teledermoscopy feasible
4
feasible adjunct
4
adjunct smartphone
4
smartphone imaging
4

Similar Publications

Direct-to-Patient Mobile Teledermoscopy: Prospective Observational Study.

JMIR Dermatol

February 2024

Department of Dermatology, School of Medicine, University of California San Francisco, San Francisco, CA, United States.

Direct-to-patient mobile teledermoscopy is a feasible and useful adjunct to smartphone imaging for monitoring patient-identified lesions of concern, achieving comparable diagnostic and management accuracy as in-office dermatology.

View Article and Find Full Text PDF

Implementation of Direct-to-Patient Mobile Teledermatology in VA.

J Gen Intern Med

February 2024

Dermatology Service (190), San Francisco VA Health Care System, 4150 Clement Street, San Francisco, CA, 94121, USA.

Background: Innovative technology can enhance patient access to healthcare but must be successfully implemented to be effective.

Objective: We evaluated Department of Veterans Affairs' (VA's) implementation of My VA Images, a direct-to-patient asynchronous teledermatology mobile application enabling established dermatology patients to receive follow-up care remotely instead of in-person.

Design /participants/approach: Following pilot testing at 3 facilities, the app was introduced to 28 facilities (4 groups of 7) every 3 months using a stepped-wedge cluster-randomized design.

View Article and Find Full Text PDF

Background: A sizeable proportion of prediabetes and diabetes cases among adults in the United States remain undiagnosed. Patient-facing clinical decision support (CDS) tools that leverage electronic health records (EHRs) have the potential to increase diabetes screening. Given the widespread mobile phone ownership across diverse groups, text messages present a viable mode for delivering alerts directly to patients.

View Article and Find Full Text PDF

Background: Long-term dependence on prescribed benzodiazepines is a public health problem. Eliminating Medications Through Patient Ownership of End Results (EMPOWER) is a promising self-management intervention, delivered directly to patients as a printed booklet, that is effective in promoting benzodiazepine reduction and cessation in older adults. EMPOWER has high potential to benefit large health care systems such as the US Veterans Health Administration (VHA), which cares for many veterans who use benzodiazepines for extended periods.

View Article and Find Full Text PDF

Background: The Tailored Antiplatelet Initiation to Lessen Outcomes Due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention (TAILOR-PCI) Digital Study is a novel proof-of-concept study that evaluated the feasibility of extending the TAILOR-PCI randomized controlled trial (RCT) follow-up period by using a remote digital platform.

Objective: The aim of this study is to describe patients' onboarding, engagement, and results in a digital study after enrollment in an RCT.

Methods: In this intervention study, previously enrolled TAILOR-PCI patients in the United States and Canada within 24 months of randomization were invited by letter to download the study app.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!